Revolutionary new way to keep up with future PC developments.
New competition/help for the struggling PC sector.
PFE (Pfizer) plans on making available to the PC investing public two new, revolutionary drugs:
Viagra, a new treatment for male erectile dysfunction that will let you keep up with changes in your hard disk.
Zeldox , a schizophrenia drug that could be used to better understand operating systems
--------------------
biz.yahoo.com
Monday March 23, 11:55 am Eastern Time
Pfizer jumps after television report on Viagra
NEW YORK, March 23 (Reuters) - Shares of Pfizer Inc (PFE - news) jumped Monday after the
spotlight on its candidate impotence drug Viagra grew even brighter with a positive feature Friday on
the ABC News television program ''20/20.''
Pfizer shares were up 3-13/16 to 95-15/16 in morning trade, continuing last week's sharp rise on
expectations the U.S. Food and Drug Administration this month will approve the oral tablet
treatment for male erectile dysfunction.
''The '20/20' report could not have been more positive even if Pfizer had written the script itself,''
said Hambrecht & Quist analyst Alex Zisson.
''They interviewed a guy who used Viagra and spoke to his wife and they both said it worked very
well and had no side effects. And they said it had changed their lives,'' Zisson said, adding that all
clinicians and patients interviewed spoke favorably of the drug.
The FDA, which is reviewing Viagra on an expedited six-month timetable, is expected to decide by
March 29 whether to grant marketing approval.
Some analysts have predicted Viagra, if approved, will generate revenues of $2 billion by the year
2001 and sales of $5 billion or more in subsequent years.
However, others say market hopes for the drug are overly exuberant and that a sales disappointment
could pressure Pfizer stock, now trading at about 47 times projected 1998 earnings, compared with
a P/E ratio of 33 for the drug group.
Pfizer shares have jumped 12 percent since March 13, helped by snowballing media attention on
Viagra (sildenafil) as it heads closer to drugstore shelves.
Pfizer is also awaiting FDA approval this month for Zeldox (ziprasidone), a schizophrenia drug that
would compete with Eli Lilly and Co.'s (LLY - news) blockbuster Zyprexa (olanzapine) and with
Zeneca Group Plc's (quote from Yahoo! UK & Ireland: ZEN.L) Seroquel (quetiapine).
---------------------
Best wishes/happy investing
Larry |
